Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 1
1987 1
1988 2
1989 1
1990 3
1991 3
1992 4
1993 3
1994 7
1995 7
1996 9
1997 5
1998 5
1999 18
2000 9
2001 7
2002 9
2003 5
2004 9
2005 5
2006 6
2007 11
2008 7
2009 7
2010 9
2011 10
2012 11
2013 8
2014 7
2015 6
2016 5
2017 6
2018 3
2019 4
2020 4
2021 3
2022 3
2023 8
2024 5
2025 6
2026 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

237 results

Results by year

Filters applied: . Clear all
Page 1
Asundexian for Secondary Stroke Prevention.
Sharma M, Dong Q, Hirano T, Kasner SE, Saver JL, Masjuan J, Demchuk AM, Cordonnier C, Bereczki D, Tsivgoulis G, Veltkamp R, Staikov I, Bae HJ, Campbell BCV, Zini A, Lee IH, Kovar M, Mikulik R, Lemmens R, Ferro JM, Robinson T, Christensen H, Ozturk S, Leker RR, Turcani P, Slowik A, Amaya P, Hoo FK, De Marchis GM, Knoflach M, Sylaja PN, Putaala J, Coutinho JM, van der Worp HB, Miglane E, Matijošaitis V, Lindgren AG, Sampaio Silva G, Sandset EC, Turuspekova ST, Amarenco P, Sheth KN, Smith EE, Eikelboom JW, Joundi RA, Schulze K, Xu L, Heenan L, Colorado P, Keller L, Muehlhofer E, Neumann C, Mundl H, Shoamanesh A; OCEANIC-STROKE Investigators. Sharma M, et al. N Engl J Med. 2026 Apr 16;394(15):1467-1479. doi: 10.1056/NEJMoa2513880. N Engl J Med. 2026. PMID: 41985132 Clinical Trial.
Tolebrutinib versus Teriflunomide in Relapsing Multiple Sclerosis.
Oh J, Arnold DL, Cree BAC, Ionete C, Kim HJ, Sormani MP, Syed S, Chen Y, Maxwell CR, Benoit P, Turner TJ, Wallstroem E, Wiendl H; Tolebrutinib Phase 3 GEMINI 1 and 2 Trial Group. Oh J, et al. N Engl J Med. 2025 May 15;392(19):1893-1904. doi: 10.1056/NEJMoa2415985. Epub 2025 Apr 8. N Engl J Med. 2025. PMID: 40202623 Clinical Trial.
Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials.
Montalban X, Vermersch P, Arnold DL, Bar-Or A, Cree BAC, Cross AH, Kubala Havrdova E, Kappos L, Stuve O, Wiendl H, Wolinsky JS, Dahlke F, Le Bolay C, Shen Loo L, Gopalakrishnan S, Hyvert Y, Javor A, Guehring H, Tenenbaum N, Tomic D; evolutionRMS investigators. Montalban X, et al. Lancet Neurol. 2024 Nov;23(11):1119-1132. doi: 10.1016/S1474-4422(24)00328-4. Epub 2024 Sep 19. Lancet Neurol. 2024. PMID: 39307151 Clinical Trial.
Resilience to diabetic retinopathy.
Serikbaeva A, Li Y, Ma S, Yi D, Kazlauskas A. Serikbaeva A, et al. Among authors: kazlauskas a. Prog Retin Eye Res. 2024 Jul;101:101271. doi: 10.1016/j.preteyeres.2024.101271. Epub 2024 May 11. Prog Retin Eye Res. 2024. PMID: 38740254 Free PMC article. Review.
PDGFs and their receptors.
Kazlauskas A. Kazlauskas A. Gene. 2017 May 30;614:1-7. doi: 10.1016/j.gene.2017.03.003. Epub 2017 Mar 4. Gene. 2017. PMID: 28267575 Free PMC article. Review.
Activin A Limits VEGF-Induced Permeability via VE-PTP.
Baccouche B, Lietuvninkas L, Kazlauskas A. Baccouche B, et al. Among authors: kazlauskas a. Int J Mol Sci. 2023 May 12;24(10):8698. doi: 10.3390/ijms24108698. Int J Mol Sci. 2023. PMID: 37240047 Free PMC article.
Proliferative diabetic retinopathy subtypes defined by immune defense and endothelial mitochondrial dysfunction.
McCann MA, Baccouche B, Li Y, Roy P, Sheth N, Lim JI, Mieler WF, Chau FY, Ulanski LJ, Chan RVP, Munro M, Hyde RA, Berek C, Ong A, De S, Siedlecki B, Chee RI, Leiderman YI, Heiferman MJ, Kazlauskas A. McCann MA, et al. Among authors: kazlauskas a. Signal Transduct Target Ther. 2025 Oct 22;10(1):350. doi: 10.1038/s41392-025-02448-9. Signal Transduct Target Ther. 2025. PMID: 41120275 Free PMC article.
Pericytes and ocular diseases.
Motiejūnaite R, Kazlauskas A. Motiejūnaite R, et al. Among authors: kazlauskas a. Exp Eye Res. 2008 Feb;86(2):171-7. doi: 10.1016/j.exer.2007.10.013. Epub 2007 Nov 5. Exp Eye Res. 2008. PMID: 18078933 Review.
237 results